Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction

Recruiting now · Not applicable

Conditions studied: Psoriasis, Atopic Dermatitis, Xerosis, Contact Dermatitis

In brief

The goal of this clinical trial is to learn if a novel barrier topical product works to treat barrier dysfunction in adults. It will also learn about the safety of the novel barrier topical product. The main questions it aims to answer are: Does the novel barrier topical product improve skin hydration, skin sebum, redness, and pigmentation? Does it improve subjective dryness and itch? Researchers will compare the novel barrier topical product to petrolatum (a gold standard occlusive barrier repair agent) to see how they are comparable in treating skin barrier dysfunction. Participants will: Apply the novel barrier topical product or petrolatum twice a day for 28 days Visit the clinic once a week for checkups and tests Keep a diary of their application of the assigned product

Key facts

Study ID

NCT07183423

Run by

Makati Medical Center

People needed

26

Starts

2025-08-31

Expected to finish

2025-10-01

Last updated by the study team

2025-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of mild skin barrier dysfunction, including:
• Mild to moderate atopic dermatitis, defined as SCORAD ≤ 50, and/or not currently requiring topical corticosteroids or immunomodulators.
• Mild to moderate chronic plaque psoriasis, defined as total body surface area (BSA) involved: ≤3% to 10%.
• Contact dermatitis
• Seasonal xerosis or clinically evident skin dryness
• Symmetrical or bilateral test areas available (volar forearm)
• Willing and able to provide informed consent and adhere to study procedures

You may not qualify if…

• Failure to meet any of the above inclusion criteria
• Severe atopic dermatitis or psoriasis requiring systemic or high-potency topical treatment
• Use of corticosteroids, calcineurin inhibitors, biologics, or phototherapy within 2 weeks
• Open wounds or evidence of secondary infection at test sites
• Pregnant or breastfeeding women
• Multiple nevi, tattoos, dense body hair in the test areas
• Debilitated or immunocompromised subjects
• Known or suspected hypersensitivity to the interventional product (or its ingredients) or petrolatum
• Refusal or failure to comply with the schedule of visits at the test site.

Where it is running

• VMV Skin Research Center & Clinics — Makati City, National Capital Region, Philippines (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.